مقالات

 

دکتر محمدرضا آقاصادقی

1-Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine /candidate+Iranian Journal of Microbiology /2025 Aug;17(4):636–643. doi: 10.18502/ijm.v17i4.19257 /https://pmc.ncbi.nlm.nih.gov/articles/PMC12331461/

 

 

2-Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics -Journal of Virus Eradication/Volume 11, Issue 1, March 2025, 100578

 

 

3-Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality -/Nucleosides Nucleotides Nucleic Acids 2025;44(1):41-56doi: 10.1080/15257770.2024.2344179. Epub 2024 Apr 25

 

 

4-Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation /BMC Complement Med The /2024 Oct 2;24(1):350.doi: 10.1186/s12906-024-04634-8/https://pmc.ncbi.nlm.nih.gov/articles/PMC11448447

 

 

5-Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses /Mol Biotechnol 2024 Sep;66(9):2362-2380 doi: 10.1007/s12033-023-00867-z. Epub 2023 Sep 16.

 

 

6-Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate /SCIENCE DIRECT/Volume 10, Issue 15, 15 August 2024, e35124 

 

7-Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication /J Infect Public Health/ 2024 Aug;17(8):102489.doi: 10.1016/j.jiph.2024.102489. Epub 2024 Jul/https://www.sciencedirect.com/science/article/pii/S1876034124002235?via%3Dihub

 

 

8-DOE-based process optimization for development of efficient methods for purification of recombinant hepatitis B surface antigen from Pichia pastoris feedstock using Capto adhere resin /Microbial Pathogenesis/Volume 10, Issue 15, 15 August 2024, e35124 /https://www.sciencedirect.com/science/article/pii/S2405844024111553

 

 

9-Designing the fusion protein of rotavirus VP8 and hepatitis A virus VP1 and evaluating the immunological response in BALB/c mice /SCIENCE DIRECT/IRANIAN JORNAL OF MICROBIOLOGY/Vol 16 No 3 (2024) /https://ijm.tums.ac.ir/index.php/ijm/article/view/4600

 

 

10-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial /Frontires in immunology/Volume 15 - 2024 /

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1332425/full

 

 

11-Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects /

 

12-Blood and sputum microbiota composition in Afghan immigrants and Iranian subjects with pulmonary tuberculosis/ Iran J Microbiol 2024 Jun;16(3):342-350.

 doi: 10.18502/ijm.v16i3.15766./https://pmc.ncbi.nlm.nih.gov/articles/PMC11245349/

 

 

13-Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes/nature/2023/https://www.nature.com/articles/s41598-023-37614-y

 

 

14-Signal amplification of a quartz crystal microbalance immunosensor by gold nanoparticles-polyethyleneimine for hepatitis B biomarker detection/nature/2023/https://www.nature.com/articles/s41598-023-48766-2

 

 

15-Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 /Future virol/2022/https://pmc.ncbi.nlm.nih.gov/articles/PMC10348059/

 

 

16-Development of Soft Sensors for Online Biomass Prediction in Production of Hepatitis B Vaccine /Future virol/2022/https://pmc.ncbi.nlm.nih.gov/articles/PMC10348059/

 

 

17-Anti-proliferative effects of cabergoline nano conjugated form on lung cancer cells /Journal of Drug Delivery Science and Technology

18-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease/Art Med Res/2023 Feb;54(2):105-112.doi: 10.1016/j.arcmed.2022.12.010. Epub 2022 Dec 28/https://pmc.ncbi.nlm.nih.gov/articles/PMC9794484/

 

19-Metal-enhanced bioluminescence by detergent stabilized Ag and Au nanoparticles/Talanta,Volume 254, 1 March 2023, 124157 /https://www.sciencedirect.com/science/article/abs/pii/S0039914022009535

 

 

20-Evaluation of miR-let-7f, miR-125a, and miR-125b expression levels in sputum and serum samples of Iranians and Afghans with pulmonary tuberculosis/Iran J Microbial/https://pmc.ncbi.nlm.nih.gov/articles/PMC10628080/

 

 

21-Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c/Patog Dis ,2023 Jan 17:81:ftad021.

 doi: 10.1093/femspd/ftad021./https://academic.oup.com/femspd/article/doi/10.1093/femspd/ftad021/7259893?login=false

 

 

22-Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection /Virology Jornal/https://virologyj.biomedcentral.com/articles/10.1186/s12985-022-01885-0

 

 

23-Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/Virology Jornal/2022/https://virologyj.biomedcentral.com/articles/10.1186/s12985-022-01903-1

 

 

 

24-Predictive Value Alteration of Laboratory Routine and Ferritin/Transferrin Ratio in Monitoring of COVID-19 Patients /Clin Lab/2022 Oct 1;68(10).

 doi: 10.7754/Clin.Lab.2022.211213./https://www.clin-lab-publications.com/article/4277

 

 

25-Tumor cell-based vaccine: an effective strategy for eradication of cancer cells/IMUNOTHERAPY/2022 Jun;14(8):639-654.doi: 10.2217/imt-2022-0036./

https://www.tandfonline.com/doi/10.2217/imt-2022-0036?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

 

 

 

26-Association between serum inflammatory parameters and the disease severity in COVID-19 patients-/

J Clin Lab//2021 Dec 7;36(1):e24162 /https://pmc.ncbi.nlm.nih.gov/articles/PMC8761446

 

 

27-Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling,2 Synthesis and Biological Evaluation/Iran J Pharm Res/2021 Dec 14;21(1):e123827 /https://pmc.ncbi.nlm.nih.gov/articles/PMC9191218/

 

 

28-A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-Clin Lab/BETHAM SCIENCE/Source: Coronaviruses, Volume 3, Issue 2, Feb 2022, p. 29 - 38/https://www.benthamdirect.com/docserver/fulltext/covid/3/2/s7.pdf?expires=1761457069&id=id&accname=guest&checksum=DF4BA8353323FFD8717D1BDB8C8988F8

 

 

29-The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients/Virol J/2021 Nov 14;18(1):221 /https://pmc.ncbi.nlm.nih.gov/articles/PMC8590865/

 

 

30-Lamivudine-conjugated and efavirenz-loaded G2 dendrimers: Novel anti-retroviral nano drug delivery systems/IET Biotechnal/2021 Jun 10;15(7):627–637. /https://pmc.ncbi.nlm.nih.gov/articles/PMC8675833/

 

 

31-Changes in the Distribution Pattern of Hepatitis C Virus Genotypes Among Chronic Hepatitis Patients: a Cross-Sectional Study/Clin Lab/2021 Aug 1;67(8) /https://www.clin-lab-publications.com/article/3849

 

32-The Effects of Human Reoviruses on Cancer Cells Derived from Hepatocellular Carcinoma Biopsies/Clin Lab/2021 Mar 1;67(3) /https://www.clin-lab-publications.com/article/3683

 

 

33-Importance of evaluating occult HBV risk factors in a low endemic area for HBV infection/Wien Med Wochenschr2021 Feb;171(1-2):16-17 /https://link.springer.com/article/10.1007/s10354-020-00784-9

 

 

34-Full-length Sequencing and Genotyping of Hepatitis A Virus among Acute Hepatic Patients in Iran/Clin LAB/2021 May 1;67(5) /https://www.clin-lab-publications.com/article/3764

 

 

35-Impact of the gut microbiota on vaccine responses/Gut Microbes/2025 Dec;17(1):2549585 /https://pmc.ncbi.nlm.nih.gov/articles/PMC12407820/

 

 

36-Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis/Plos One/2020 Oct 15;15(10):e0240577/https://pmc.ncbi.nlm.nih.gov/articles/PMC7561160/

 

 

37-No evidence of occult HBV infection in population born after mass vaccination/Wien Med Wochenschr2020 Jun;170(9-10):218-223 /

https://pubmed.ncbi.nlm.nih.gov/32274600/

 

38-Novel delivery based anionic linear globular dendrimerg2-zidovudine nano-conjugate significantly decreased retroviral activity/Pak J Pharm Sci2020 Mar;33(2):705-714./https://pubmed.ncbi.nlm.nih.gov/32276917/

 

40-Design, Synthesis, Molecular Modeling and Anti-HIV Assay of Novel Quinazolinone Incorporated Coumarin Derivatives/Curr HIV Res. 2020;18(1):41-51/https://www.eurekaselect.com/article/102870

 

 

41-Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvantsJ Med Microbio2020 Mar;69(3):465-477 /https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.001103#tab2

 

42-Prevalence of astrovirus, adenovirus, and sapovirus infections among Iranian children with acute gastroenteritis/Gastroenterol Hepatol Bed Bench2020 Winter;13(Suppl1)/https://pmc.ncbi.nlm.nih.gov/articles/PMC7881414/

 

 

43-Comparative study of μ-stat methanol feeding control in fed-batch fermentation of Pichia pastoris producing HBsAg: an open-loop control versus recurrent artificial neural network-based feedback control/SCI/Volume94, Issue12 /https://scijournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jctb.6192

 

 

44-In vitro effect of branched polyethyleneimine (bPEI) on cells infected with human immunodeficiency virus: enhancement of viral replication/Arch Virol2019 Dec;164(12):3019-3026. /https://link.springer.com/article/10.1007/s00705-019-04426-3

 

45-Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine/IUBMB Life2019 Oct;71(10):1645-1652. /https://iubmb.onlinelibrary.wiley.com/doi/10.1002/iub.2109

 

46-Prevalence and risk factors for hepatitis B and hepatitis C exposure in Iranian prisoners: A national study in 2016/(2019)/https://brieflands.com/articles/hepatmon-91129

 

 

47-Application of recurrent neural network for online prediction of cell density of recombinant Pichia pastoris producing HBsAg/Prep Biochem Biotechnol. 2019;49(4):352-359. /https://pubmed.ncbi.nlm.nih.gov/30707051/

 

 

48-Inherent anti-HIV activity of biocompatible anionic citrate-PEG-citrate dendrimer/Mol Biol Rep2019 Feb;46(1):143-149/https://link.springer.com/article/10.1007/s11033-018-4455-6

 

 

49-Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors/Med Chem2019;15(7):755-770/https://www.eurekaselect.com/article/95316

 

 

50-Design, Synthesis, Docking Studies and Biological Activities Novel 2,3- Diaryl-4-Quinazolinone Derivatives as Anti-HIV-1 Agents/Curr HIV Res 2019;17(3):214-222/https://www.eurekaselect.com/article/100735

 

 

دکتر سید مهدی سادات

1-Novel bioinformatics approaches to design epitope-based vaccine against HIV latency by inquiring CTL epitopes and built-in adjuvants/Article number: 32809 (2025) /

https://www.nature.com/articles/s41598-025-17196-7

 

2-Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine candidate/Iran J Microbiol2025 Aug;17(4):636-643.doi: 10.18502/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12331461/

 

3-The Antitumor Effect of a Non-transforming E7 Protein Combined with a TLR7 Agonist/Iran J Allergy Asthma Immunol/ 2025 Jun 26;24(4):498-507./https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4204

 

4-The Combinatorial Effect of Ad-IL-24 and Ad-HSV-tk/GCV on Tumor Size, Autophagy, and UPR Mechanisms in Multiple Myeloma Mouse Model/Biochem Genet2025 Feb;63(1):315-330.doi: 10.1007/s10528-024-10671-2. Epub 2024 Mar 4./https://link.springer.com/article/10.1007/s10528-024-10671-2

5-Electrical vehicles impact on unbalanced distribution networks considering different loads and energy prices/Volume 10, Issue 21, 15 November 2024, e39233 /journal homepage: www.cell.com/heliyon/https://www.sciencedirect.com/science/article/pii/S2405844024152644

 

6-Retraction notice to "Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates" [Life Sci. 340 (2024) 122456]/Life Sci 2024 Aug 15:351:122831./doi: 10.1016/j.lfs.2024.122831. Epub 2024 Jun 12./

https://www.sciencedirect.com/science/article/pii/S0024320524004211?via%3Dihub/

7-Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates/Life Sci 2024 Mar 1:340:122456.doi: 10.1016/j.lfs.2024.122456. Epub 2024 Jan 23/https://pubmed.ncbi.nlm.nih.gov/38266814/

 

8-In silico designing of novel epitope-based peptide vaccines against HIV-1/Biotechnol Lett 2024 Jun;46(3):315-354.doi: 10.1007/s10529-023-03464-x. Epub 2024 Feb 26./https://pubmed.ncbi.nlm.nih.gov/38403788/

 

9-Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen/Protein Pept Lett 2024;31(10):818-826.doi: 10.2174/0109298665337811241010104557. /https://pubmed.ncbi.nlm.nih.gov/39558498/

 

10-Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope/Article number: 16801 (2023) /https://www.nature.com/articles/s41598-023-43965-3

 

11-Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c/Pathog Dis 2023 Jan 17:81:ftad021.doi: 10.1093/femspd/ftad021/DOI: 10.1093/femspd/ftad021/https://pubmed.ncbi.nlm.nih.gov/37667486/https://pubmed.ncbi.nlm.nih.gov/37667486/

 

12-A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2/Source: Coronaviruses, Volume 3, Issue 2, Feb 2022, p. 29 - 38DOI:https://doi.org/10.2174/2666796702666210122123559/-https://www.benthamdirect.com/content/journals/covid/10.2174/2666796702666210122123559

 

13-Expression and characterization of two dna constructs derived from hiv-1-vif in escherichia coli and mammalian cells/Avicenna J Med Biotechnol2021 Jul-Sep;13(3):131-135.doi: 10.18502/ajmb.v13i3.6369. /https://pubmed.ncbi.nlm.nih.gov/34484642/

 

14-HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c/Curr Drug Deliv2021;18(7):1014-1021.doi: 10.2174/1567201818666210101113601/https://pubmed.ncbi.nlm.nih.gov/33388019/

 

15-Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccineVirus Res 2021 Jun:298:198403.doi: 10.1016/j.virusres.2021.198403. Epub 2021 Mar 26/https://pubmed.ncbi.nlm.nih.gov/33775753/

16-Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19/Mol Biotechnol 2021 May;63(5):389-409.doi: 10.1007/s12033-021-00303-0. Epub 2021 Feb 24./https://pubmed.ncbi.nlm.nih.gov/33625681/

 

17-The next generation of HCV vaccines: a focus on novel adjuvant development/Expert Rev Vaccines2021 Jul;20(7):839-855.doi: 10.1080/14760584.2021.1941895. Epub 2021 Jun 28./https://www.tandfonline.com/doi/10.1080/14760584.2021.1941895?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

 

18-HR9: An important cell penetrating peptide for delivery of HCV NS3 DNA into HEK-293T cells/Avicenna J Med Biotechno2020 Jan-Mar;12(1):44-51/https://pmc.ncbi.nlm.nih.gov/articles/PMC7035460/

 

19-Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles/Curr Drug Deliv 2020;17(5):387-395.doi: 10.2174/1567201817666200317121728. /https://www.eurekaselect.com/article/105307

 

20-Effective Delivery of Nef-MPER-V3 Fusion Protein Using LDP12 Cell Penetrating Peptide for Development of Preventive/Therapeutic HIV-1 Vaccine/Protein Pept Lett 2020;27(11):1151-1158.doi: 10.2174/0929866527666200504121400./https://www.eurekaselect.com/article/106340

 

21-Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide/Curr HIV Res 2020;18(5):315-323.doi: 10.2174/1570162X18666200612151925. /https://www.eurekaselect.com/article/107308

 

22-Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide//Curr HIV Res 2020;18(5):315-323.doi: 10.2174/1570162X18666200612151925. /https://www.eurekaselect.com/article/107308

 

23-G2 dendrimer as a carrier can enhance immune responses against HCV-NS3 protein in BALB/c mice/Avicenna J Med Biotechnol2019 Oct-Dec;11(4):292-298. /https://pmc.ncbi.nlm.nih.gov/articles/PMC6925401/

 

24-Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides/Biotechnol Lett 2019 Nov;41(11):1283-1298 doi: 10.1007/s10529-019-02734-x. Epub 2019 Sep 17./https://link.springer.com/article/10.1007/s10529-019-02734-x

 

25-Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine/IUBMB Life2019 Oct;71(10):1645-1652doi: 10.1002/iub.2109. Epub 2019 Jul 12./https://iubmb.onlinelibrary.wiley.com/doi/10.1002/iub.2109

 

26-Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses/Immunol Lett2019 Aug:212:70-80.doi: 10.1016/j.imlet.2019.06.011. Epub 2019 Jun 26./https://www.sciencedirect.com/science/article/abs/pii/S0165247819300264?via%3Dihub

 

27-Updated Studies on the Development of HIV Therapeutic Vaccine/Curr HIV Res 2019;17(2):75-84.doi: 10.2174/1570162X17666190618160608. /https://www.eurekaselect.com/article/99002

 

28-Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System/Iran Biomed J 2019 Jul;23(4):235-45 doi: 10.29252/.23.4.235. Epub 2018 Oct 3./https://pmc.ncbi.nlm.nih.gov/articles/PMC6462289/

 

29-Induction of a Robust Humoral Response using HIV-1 VLP^MPER-V3 as a Novel Candidate Vaccine in BALB/c Mice/Curr HIV Res2019;17(1):33-41.doi: 10.2174/1570162X17666190306124218. /https://pubmed.ncbi.nlm.nih.gov/30843489/

 

30-Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells/Curr HIV Res2019;17(6):408-428doi: 10.2174/1570162X17666191121114522. /https://pubmed.ncbi.nlm.nih.gov/31755394/

 

31-The distinct role of small heat shock protein 20 on HCV NS3 expression in HEK-293T cell line/Avicenna J Med Biotechnol2018 Jul-Sep;10(3):152-157. /https://pubmed.ncbi.nlm.nih.gov/30090208/

 

32-Design, Synthesis, and Anti-HIV-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-Carboxylic Acid Derivatives/Chem Biodivers2018

 Apr;15(4):e1700502.doi: 10.1002/cbdv.201700502. Epub 2018 Apr 10./https://pubmed.ncbi.nlm.nih.gov/29411517/

 

33-In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate/Clin Lab 2018 Oct 1;64(10):1641-1647.doi: 10.7754/Clin.Lab.2018.180406. /https://www.clin-lab-publications.com/article/2857

 

34-The Effect of Over-Expression of miR-20a on Cell Proliferation of Human T Cell Leukemia Cell Line/Chem Biodivers 2017 Dec;14(12). doi: 10.1002/cbdv.201700295. Epub 2017 Dec 15./https://onlinelibrary.wiley.com/action/oidcStart?redirectUri=%2Fdoi%2F10.1002%2Fcbdv.201700295

 

35-Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 4-[4-Arylpyridin-1(4H)-yl]benzoic Acid Derivatives as Anti-HIV-1 Agents/Curr HIV Res2017;15(6):434-439. doi: 10.2174/1570162X15666171017122229./https://www.eurekaselect.com/article/86402

 

36-Construction and Production of HIV-VLP Harboring MPER-V3 for Potential Vaccine Study/

Immunol Lett2017 Nov:191:16-22.doi: 10.1016/j.imlet.2017.09.005. Epub 2017 Sep 14./https://linkinghub.elsevier.com/retrieve/pii/S0165-2478(17)30392-9

 

37-Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity/Immunol Lett2017 Nov:191:16-22. doi: 10.1016/j.imlet.2017.09.005. Epub 2017 Sep 14./https://www.sciencedirect.com/science/article/abs/pii/S0165247817303929?via%3Dihub

 

 

38-miR-17 and miR-20a Expression in IL-2 Signaling Pathway in Jurkat T Cells/Volume 32, pages 224–229, (2017)/Published: 30 May 2018/https://link.springer.com/article/10.3103/S0891416817040061

 

 

39-Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model/Immunol Lett2017 Aug:188:38-45.doi: 10.1016/j.imlet.2017.06.003. Epub 2017 Jun 8./https://www.sciencedirect.com/science/article/abs/pii/S0165247817301256?via%3Dihub

 

 

40-Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity/Microb Pathog2017 Jul:108:32-39.doi: 10.1016/j.micpath.2017.04.037. Epub 2017 Apr 28./https://www.sciencedirect.com/science/article/abs/pii/S0882401016307719?via%3Dihub

 

 

41-The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell/Curr Drug Deliv 2017;14(4):536-542.doi: 10.2174/1567201813666161006114448. /https://www.eurekaselect.com/article/78786

 

 

 

42-Delivery of HIV-1 Nef Protein in Mammalian Cells Using Cell Penetrating Peptides as a Candidate Therapeutic Vaccine/

Published: 27 July 2016Volume 23, pages 145–153, (2017)/https://link.springer.com/article/10.1007/s10989-016-9547-3

 

 

43-Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines/

Biomed Pharmacother 2017 Jan:85:148-154. doi: 10.1016/j.biopha.2016.11.115. Epub 2016 Dec 5./https://www.sciencedirect.com/science/article/abs/pii/S0753332216317930?via%3Dihub

 

 

44-IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C/Arch Virol 2017 Jan;162(1):181-189. doi: 10.1007/s00705-016-3095-1. Epub 2016 Oct 6./https://link.springer.com/article/10.1007/s00705-016-3095-1

 

 

45-From in-silico immunogenicity verification to in vitro expression of recombinant Core-NS3 fusion protein of HCV/

Bratisl Lek Listy 2017;118(4):189-195.doi: 10.4149/BLL_2017_038. /https://www.elis.sk/index.phppage=shop.product_details&flypage=flypage.tpl&product_id=5182&category_id=135&option=com_virtuemart

 

 

46-Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model/

Bratisl Lek Listy 2017;118(9):564-569. doi: 10.4149/BLL_2017_108./https://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=5433&category_id=135&option=com_virtuemart&vmcchk=1&Itemid=1پ

 

 

47-Interleukin 20 Gene Polymorphism (rs1518108) is not Associated with Sustained Virological Response in Iranian Patients with Hepatitis C Virus Infection/

 

48-Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected Patients/Clin Lab 2016 Oct 1;62(10):1919-1926. doi: 10.7754/Clin.Lab.2016.160205./https://www.clin-lab-publications.com/article/2271

 

دکتر پونه رحیمی

1-Akkermansia muciniphila and Its Extracellular Vesicles Affect Endocannabinoid System in in vitro Model/Digestion2025;106(4):338-348.doi: 10.1159/000543446. Epub 2025 Mar 13.https://karger.com/dig/article-abstract/106/4/338/923216/Akkermansia-muciniphila-and-Its-Extracellular?redirectedFrom=fulltext

 

2-Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality/Nucleosides Nucleotides Nucleic Acids2025;44(1):41-56.doi: 10.1080/15257770.2024.2344179. Epub 2024 Apr 25./https://pubmed.ncbi.nlm.nih.gov/38660988/

 

3-Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication/J Infect Public Health2024 Aug;17(8):102489doi: 10.1016/j.jiph.2024.102489. Epub 2024 Jul 2 https://www.sciencedirect.com/science/article/pii/S1876034124002235?via%3Dihub

 

4-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial/Front Immunol2024 Apr 8:15:1332425.doi: 10.3389/fimmu.2024.1332425. eCollection 2024./https://pmc.ncbi.nlm.nih.gov/articles/PMC11036872/

 

5-Investigating the correlation between the frequency of single nucleotide polymorphisms in the IFNAR2 gene with the severity of the Covid-19 disease/Volume 81, Issue 8 (November 2023)   Tehran Univ Med J 2023, 81(8): 588-595 /https://tumj.tums.ac.ir/article-1-12744-en.html

 

6-Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1 /Biochem Biophys Res Commun 2024 May 14:708:149769.doi: 10.1016/j.bbrc.2024.149769. Epub 2024 Mar 11/https://www.sciencedirect.com/science/article/abs/pii/S0006291X2400305X?via%3Dihub

 

7-Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19/Future Virol 2023 Jun;18(9):563-574doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13./https://pmc.ncbi.nlm.nih.gov/articles/PMC10348059/

 

8-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019/Arch Med Res2023 Feb;54(2):105-112. doi: 10.1016/j.arcmed.2022.12.010. Epub 2022 Dec 28./https://pmc.ncbi.nlm.nih.gov/articles/PMC9794484/

 

9-Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/Virol J 2022 Oct 3;19(1):156.doi: 10.1186/s12985-022-01885-0. /https://pmc.ncbi.nlm.nih.gov/articles/PMC9527726/

 

10-Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection/Virol J 2022 Oct 31;19(1):171. doi: 10.1186/s12985-022-01903-1./https://pmc.ncbi.nlm.nih.gov/articles/PMC9624030/

 

11-Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study/

12-The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients/Virol J 2021 Nov 14;18(1):221.doi: 10.1186/s12985-021-01692-z. /https://pmc.ncbi.nlm.nih.gov/articles/PMC8590865/

 

 

13-Lamivudine-conjugated and efavirenz-loaded G2 dendrimers: Novel anti-retroviral nano drug delivery systems/IET Nanobiotechnol 2021 Sep;15(7):627-637.doi: 10.1049/nbt2.12060. Epub 2021 Jun 10./https://pmc.ncbi.nlm.nih.gov/articles/PMC8675833/

 

 

14-Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection/Front Microbiol

 

15-Impact of the gut microbiota on vaccine responses/Volume 30, Issue 193 (1-2021)  J Mazandaran Univ Med Sci 2021, 30(193): 84-102 /https://jmums.mazums.ac.ir/article-1-15979-en.html

 

16-Novel delivery based anionic linear globular dendrimerg2-zidovudine nano-conjugate significantly decreased retroviral activity/Pak J Pharm Sci 2020 Mar;33(2):705-714./https://pubmed.ncbi.nlm.nih.gov/32276917/

 

17-Coronaviruses as the emerging threats for human health: should we be prepared for the future outbreaks of new coronaviruses?/Bratisl Lek Listy2020;121(10):733-741.doi: 10.4149/BLL_2020_120. /https://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=6926&category_id=158&option=com_virtuemart

 

18-G2 dendrimer as a carrier can enhance immune responses against HCV-NS3 protein in BALB/c mice/Avicenna J Med Biotechnol 2019 Oct-Dec;11(4):292-298/https://pmc.ncbi.nlm.nih.gov/articles/PMC6925401/

 

19-Carboxymethyl dextran-trimethyl chitosan coated superparamagnetic iron oxide nanoparticles: An effective siRNA delivery system for HIV-1 Nef/

 

20-Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle/Int J Biol Macromol 2019 May 15:129:305-315.doi: 10.1016/j.ijbiomac.2019.02.036. Epub 2019 Feb 6./https://www.sciencedirect.com/science/article/abs/pii/S0141813018371265?via%3Dihub

 

 

21-Molecular Approach for HIV-1 Replication Inhibition: Assessment of Different siRNAs Targeting Tat and Nef Genes to Effectively Suppress their ExpressioN/

 

22-Rabies Prophylaxis Strategy in Iran, a Need for an Alternative Strategy: Would the Essen Regimen be Replaced by Zagreb Protocol?/Clin Lab2019 Jan 1;65(1).doi: 10.7754/Clin.Lab.2018.180619. /https://www.clin-lab-publications.com/article/2902

 

 

23-Comparison of transfection efficiency of polymer-based and lipid-based transfection reagents/Bratisl Lek Listy 2018;119(11):701-705 doi: 10.4149/BLL_2018_125/https://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=5938&category_id=142&option=com_virtuemart

 

 

24-Truncated JFH1 E2 Protein: Is it Reliable to be Used in Diagnostic ELISA Test and as a Protein-Based Vaccine Candidate؟/Protein Pept Lett 2018 Feb 8;24(12):1179-1184.doi: 10.2174/0929866524666171009164314. /https://www.eurekaselect.com/article/86285

 

 

25-The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model/Drug Deliv 2016 Oct;23(8):2852-2859. doi: 10.3109/10717544.2015.1108375. Epub 2015 Nov 11./https://www.tandfonline.com/doi/10.3109/10717544.2015.1108375?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

 

 

 

26-Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected PatientsClin Lab 2016 Oct 1;62(10):1919-1926.doi: 10.7754/Clin.Lab.2016.160205. /https://www.clin-lab-publications.com/article/2271

 

 

27-HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin/Sci Rep2016 Aug 23:6:31924.doi: 10.1038/srep31924. /https://pmc.ncbi.nlm.nih.gov/articles/PMC4994036/

 

 

28-Designing a recombinant construct of pEGFP-N1 containing the full length of human immunodeficiency virus-1 (HIV-1) Vpr gene/Volume 26, Issue 137 (6-2016)                   J Mazandaran Univ Med Sci 2016, 26(137): 23-31  /https://jmums.mazums.ac.ir/article-1-7700-en.html

 

 

29-Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C/Clin Lab 2016;62(4):609-14.doi:10.7754/clin.lab.2015.150807./https://pubmed.ncbi.nlm.nih.gov/27215079/

 

 

30-Evaluation of truncated HCV-NS3 protein for potential applications in immunization and diagnosis/

Clin Lab2016 Jul 1;62(7):1271-1278. doi:

 10.7754/Clin.Lab.2015.151118./https://www.clin-lab-publications.com/article/2073

 

 

31-Impact of human enterovirus 71 genotypes in meningoencephalitis in Iran/Jundishapur J Microbiol . 2015 Dec 26;8(12):e27113. doi: 10.5812/jjm.27113. eCollection 2015 Dec./https://pmc.ncbi.nlm.nih.gov/articles/PMC4744466/

 

 

دکتر گلناز بهرامعلی

1-A novel multi–epitope-based peptide recombinant influenza A vaccine prototype utilizing neuraminidase and hemagglutinin surface proteins: From in silico to preliminary study-2025

 

2-Antimicrobial Screening and Molecular Docking Simulation of 2-Aminopyrimidin-1-Ium 4-Nitrobenzenesulfonate as a New Proton Transfer Compound-2025

 

3-Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system-2025

 

4-Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics-2025

 

5-In silico design of a trivalent multi-epitope global-coverage vaccine-candidate protein against influenza viruses: evaluation by molecular dynamics and immune system simulation-2025

 

6-Synthesis, Characterization and Biological Evaluation of a Sulfonamide-Based Antimicrobial Agent-2025

 

7-Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses-2025

 

8-Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication-2025

 

9-The Impact of Probiotic Supplementation on Weight and Body Composition in Older Adults: A Systematic Review-2024

 

10-Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies-2024

 

11-Investigating the Effects of HMGB1 Overexpression on Colorectal Cancer Cell Migration via Oncolytic Herpes simplex Virus Type 1 (oHSV-1)-2024

 

12-Designing the fusion protein of rotavirus VP8 and hepatitis A virus VP1 and evaluating the immunological response in BALB/c mice-2024

 

13-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial-2024

 

14-An Overview on the Pathophysiological Roles of microRNA-802: a Literature Review-2023

 

15-In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines-2023

 

16-Discordant immune response among treatment experienced patients infected with HIV-1: Crosstalk between MiRNAs expression and CD4+ T cells count-2023

 

17-Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls-2023

 

18-Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c-2023

 

19-Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia-2023

 

20-The global scientific publications on gut microbiota in type 2 diabetes; a bibliometric, Scientometric, and descriptive analysis-2022

 

21-RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis-2022

 

22-Differential gene expression of BCL-2, ZEB2-AS1 and BALR-2 in prostate cancer and benign prostatic hyperplasia-2022

 

23-Bioinformatic Investigation of Micro RNA-802 Target Genes, Protein Networks, and Its Potential Prognostic Value in Breast Cancer-2022

 

24-Immunoinformatics Evaluation of a Fusion Protein Composed of Leishmania infantum LiHyV and Phlebotomus kandelakii Apyrase as a Vaccine Candidate against Visceral Leishmaniasis-2022

 

25-Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19-2021

 

26-Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection-2021

 

27-Full-length Sequencing and Genotyping of Hepatitis A Virus among Acute Hepatic Patients in Iran-2021

 

28-Impact of the gut microbiota on vaccine responses-2021

 

29-Pulmonary Infection Related to Mimivirus in Patient with Primary Ciliary Dyskinesia-2021

 

30-The regulation of Niemann-Pick C1-Like 1 (NPC1L1) gene expression in opposite direction by Bacteroides spp. and related outer membrane vesicles in Caco-2 cell line-2021

 

31-Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran-2019

 

32-Rabies Prophylaxis Strategy in Iran, a Need for an Alternative Strategy: Would the Essen Regimen be Replaced by Zagreb Protocol?-2019

 

33-In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate-2019

 

34-Enhancement of hepatitis E virus DNA vaccine immunity by beclin-1-mediated autophagy-2017

 

35-A network biology approach to understanding the importance of chameleon proteins in human physiology and pathology-2017

 

دکتر اعظم بوالحسنی

1-Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study-2025

 

2-Immunoinformatics study of CD40 ligand-targeting vaccine constructs: a novel immunotherapeutic approach-2025

 

3-HR9 cell-penetrating peptide: An effective delivery approach of gene editing vectors for tumor treatment-2025

 

4-Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design-2025

 

5-Investigation of the Potency of KALA and REV Cell-Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct-2025

 

6-Antitumor Effects of HPV E7 and L1-E7 Multiepitope DNA Constructs Delivered by Synthetic and Arginine-Rich Cell Penetrating Peptides

 

7-Editorial: The global phenotypic diversity of HIV-1: implications for pathogenesis, vaccine, and cure-2025

 

8-Immunotherapeutic effects of TCL-E5 and TCL-E5-pulsed DCs: two novel HPV therapeutic vaccine candidates-2025

 

9-noinformatics Analysis of Potent Therapeutic Formulations for the Development of HIV-1 Nefmut-Carrying Engineered Exosomes-2025

 

10-Unveiling the Immunostimulatory Potential of the HSPA1A Mini-Chaperones Compared to the HSPA1A and HSP27 Chaperones: In Silico and In Vitro Insights for Vaccine Development-2025

 

11-Unveiling the Immunostimulatory Potential of the HSPA1A Mini-Chaperones Compared to the HSPA1A and HSP27 Chaperones: In Silico and In Vitro Insights for Vaccine Development-2025

 

12-Peptide-Membrane Docking and Molecular Dynamic Simulation of In Silico Detected Antimicrobial Peptides from Portulaca oleracea's Transcriptome-2025

 

13-Erratum: Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer (Molecular Therapy: Oncology (2024) 32(1), (S2950329924000304), (10.1016/j.omton.2024.200788))-2024

 

14-The role of T regulatory cells in the immunopathogenesis of HIV: Clinical implications-2024

 

15-Retraction notice to "Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates" [Life Sci. 340 (2024) 122456]-2024

 

16-Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate-2024

 

17-Engineered dendritic cells-derived exosomes harboring HIV-1 Nef^mut-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidate-2024

18-Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer-2024

 

19-Development of novel HPV therapeutic vaccine constructs based on engineered exosomes and tumor cell lysates-2024

 

20-Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations-2024

 

21-Pivotal Role of miRNA–lncRNA Interactions in Human Diseases-2024

 

22-Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects-2024

 

23-Investigation of Immunostimulatory Effects of IFN-γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV-1 Therapeutic Vaccine Candidate-2024

 

24-In silico designing of novel epitope-based peptide vaccines against HIV-1-2024

 

25-Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen-2024

 

26-Recent advances in various bio-applications of bacteria-derived outer membrane vesicles-2024

 

27-Engineered exosomes: a promising vehicle in cancer therapy-2024

 

28-HPV co-infections with other pathogens in cancer development: A comprehensive review-2023

 

29-Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections-2023

 

30-Immunoinformatics studies of heat shock proteins 27 and 70: Development of potent therapeutic vaccine constructs against human papillomavirus-related cancers-2023

 

31-Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice-2023

 

32-Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines-2023

 

33-Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases-2023

 

34-Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials-2023

 

35-Evaluation of MALAT-1 and HOTAIR LncRNAs Expression Levels in Incidence of Hemophilia-2023

 

36-LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice-2023

 

37-Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct-2023

 

38-Antiviral Peptides Derived from Plants: Their Designs and Functions-2023

 

39-Antiviral Effect of Saffron Compounds on the GP120 of HIV-1: an In Silico Study-2022

 

40-Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes-2022

 

41-In vitro Delivery of HIV-1 Nef-Vpr DNA Construct Using the Human Antimicrobial Peptide LL-37-2022

 

42-Cell penetrating peptide: A potent delivery system in vaccine development-2022

 

43-Current and future direction in treatment of HPV-related cervical disease-2022

 

44-Tumor cell-based vaccine: an effective strategy for eradication of cancer cells-2022

 

45-Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen-2022

46-Gene delivery in adherent and suspension cells using the combined physical methods-2022

 

47-Electroporation: An Effective Method For In Vivo Gene Delivery-2022

 

 

48-Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies-2022

49-Role of ROS in Triggering Death Receptor-Mediated Apoptosis-2022

 

50-In Silico and in Vivo Analysis of HIV-1 Rev Regulatory Protein for Evaluation of a Multiepitope-based Vaccine Candidate-2022

 

51-Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes-2022

 

52-In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses-2022

 

53-Combination of human papillomaviruses L1 and L2 multiepitope constructs protects mice against tumor cells-2022

 

دکتر کاظم باعثی

1-The Combinatorial Effect of Ad-IL-24 and Ad-HSV-tk/GCV on Tumor Size, Autophagy, and UPR Mechanisms in Multiple Myeloma Mouse Model-2025

 

2-Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate-2024

 

3-Stability of Neutralizing Antibody of PastoCoAd Vac

 

4-Exploring the potent in vitro antiviral activity of Faramir®: A tailored Salvia officinalis extraction utilizing the sequential solvent polarity method-2024

 

5-The investigation of the death-inducing potency of a recombinant Adenovector expressing Mda-7-tlyp-1 on different cancer cell lines-2024

 

6-Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects-2024

 

7-Inhibition of Mir-21-5p Affects the Expression of LNCRNA X-Inactive Specific Transcript and Induces Apoptosis in MCF-7 Breast Cancer Cells-2024

 

8-A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran-2024

 

9-Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy-2023

 

10-Autophagy and unfolded protein response induction: a crosstalk between street rabies virus and the host-2023

 

11-Discordant immune response among treatment experienced patients infected with HIV-1: Crosstalk between MiRNAs expression and CD4+ T cells count-2023

 

12-Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients-2023

 

13-Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design-2023

 

14-Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868]-2023

 

15-Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868]-2023

 

16-Immune-Related Gene Profile in HIV-Infected Patients with Discordant Immune Response-2023

 

17-Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein-2023

 

18-Immune-Related Gene Profile in HIV-Infected Patients with Discordant Immune Response-2021

 

19-Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein-2021

 

20-Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients-2021

 

21-Expression of mir-221, mir-29a, mir-155 and mir-146a in Peripheral Blood Mononuclear Cell (PBMC) in HIV-1 Infected Patients-2021

 

22-How Iran responded to expanding need for laboratory services for COVID-19?-2021

 

23-HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?-2021

 

24-Overexpression of Beclin1 gene leads to reduction of telomerase activity in MDCK cells and enhances apoptosis-2021

 

25-Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mice and Humans-2021

 

26-Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mice and Humans-2021

 

27-The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients-2020

 

28-In vitro effect of branched polyethyleneimine (bPEI) on cells infected with human immunodeficiency virus: enhancement of viral replication-2029

 

29-Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population-2019

 

30-THE EFFECT OF 8 WEEKS AEROBIC TRAINING ON CARDIAC PGC-1Α AND PLASMA IRISIN IN STZ-INDUCED DIABETICS’ RATS-2019

 

31-The response of insulin signaling proteins IRS1 and PTP-1B to endurance, HIIT and resistance training in rats with experimental diabetes-2019

 

32-Inherent anti-HIV activity of biocompatible anionic citrate-PEG-citrate dendrimer-2019

 

33-HIV drug resistance among naïve HIV-infected patients in Iran-2019

34-There is no Difference Between Sequences of HIV-1 Infected Patients with Stable Clinical Status and HIV-1 Reference Sequence-2019

 

35-Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology-2019

 

36-Design and Development of a Quantitative TaqMan Real-Time PCR Assay for Evaluation of HIV-1 (group M) Viral Load in Plasma Using Armored RNA Standard-2019

 

37-The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran-2019

 

38-Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran-2019

 

دکتر مجتبی حمیدی فرد

1-Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics-2025

 

2-Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses-2024

 

3-Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication-2024

 

4-Designing the fusion protein of rotavirus VP8 and hepatitis A virus VP1 and evaluating the immunological response in BALB/c mice-2024

 

5-Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial-2024

 

6-Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19-2024

 

7-Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019-2023

 

8-A quartz crystal microbalance biosensor based on polyethylenimine-modified gold electrode to detect hepatitis B biomarker-2023

 

9-Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection-2023

 

10-Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection-2022

12-Label-Free Real-Time Detection of HBsAg Using a QCM Immunosensor-2022

 

13-Changes in the Distribution Pattern of Hepatitis C Virus Genotypes Among Chronic Hepatitis Patients: a Cross-Sectional Study-2021

 

14-The Effects of Human Reoviruses on Cancer Cells Derived from Hepatocellular Carcinoma Biopsies-2021

 

15-Full-length Sequencing and Genotyping of Hepatitis A Virus among Acute Hepatic Patients in Iran-2021

 

16-HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin-2021

 

17-HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages-2021

 

18-High frequency of human papillomavirus genotype 16 among patients with Anogenital warts-2021

 

19-Prevalence and distribution of BK virus subtypes in renal transplant recipients referred to Golestan hospital in Ahvaz, Iran-2015

 

20-Prevalence of rhinovirus and respiratory syncytial virus among patients with chronic rhinosinusitis-2015

 

21-Determination of cytomegalovirus prevalence and glycoprotein B genotypes among ulcerative colitis patients in Ahvaz, Iran-2015

 

22-Occult hepatitis B virus among the patients with abnormal alanine transaminase-2014

 

23-Detection and genotyping of human papillomavirus in cervical tissue samples in Ahvaz, southwest Iran-2013